Although many studies demonstrated the aberrant expression of CYP4Z1 in many tumours, including in the breast, ovary and prostate the CYP4Z1 enzyme association with other tumours remains at the forefront of current research5–10,31. The gene discussed is CYP4Z1; the disease is neoplasm.